Results 131 to 140 of about 86,041 (331)
THE USE OF CERTAIN SULFONAMIDES IN THE TREATMENT OF EXPERIMENTAL DIABETES MELLITUS [PDF]
, 1956 A Loubatières
openalex +1 more source
Renal tubular acidosis in a mule mare
Equine Veterinary Education, EarlyView.Summary Renal tubular acidosis (RTA) in horses is differentiated into type I (distal) and type II (proximal) forms. We report the diagnostic evaluation and treatment of type I RTA in a 13‐year‐old mule mare that was referred because of lethargy and inappetence of several weeks' duration as well as lack of manure, anorexia and mild colic for 3 days.
L. Kummer, K. Lohmann, C. Arnold
wiley +1 more source
Antibiotic use in equine dentistry: What is the evidence?
Equine Veterinary Education, EarlyView.Summary Antimicrobial resistance (AMR) poses a major threat to human and veterinary health. In equine dentistry, antibiotics are commonly used despite limited evidence supporting their efficacy. While antimicrobials include antifungals, antivirals, parasiticides and antiseptics, this review focuses specifically on antibiotics, aiming to inform ...
A. Sidwell, S. L. Hole, R. Pereira
wiley +1 more source
Synthesis of sulfonamide derivatives containing the structural fragment of pyrazol-1-yl-pyridazine
, 2020 Ljudmila A. Komshina +5 more
openalex +1 more source
Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders
International Journal of Laboratory Hematology, EarlyView.ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley +1 more source
International Journal of Laboratory Hematology, EarlyView.ABSTRACT Background G6PD deficiency affects about 500 million people worldwide and is prevalent in many malaria‐endemic settings. People with G6PD deficiency are at risk of hemolysis when exposed to certain medications, including 8‐aminoquinoline drugs used to treat Plasmodium vivax malaria.
Flavia Regina Medeiros da Silva +7 more
wiley +1 more source
Making the Old New Again Through the Process of Recombinant Innovation
Journal of Product Innovation Management, EarlyView.ABSTRACT Academic Summary Recombinant innovation—the process through which atypical and unexpected combinations of knowledge generate novel outcomes—is a critical driver of organizational distinctiveness and market transformation. While prior research has focused on firm‐ and industry‐level mechanisms, less attention has been given to multilevel ...
Vittoria Magrelli +4 more
wiley +1 more source